Rua Bioscience Expands International Reach to Canada.

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com



FOR PUBLIC RELEASE
NZX Limited
Wellington

7
th
February, 2024

Rua Bioscience Expands International Reach to Canada.

Tairawhiti, New Zealand – Rua Bioscience, a leading innovator in medicinal cannabis cultivation, is
pleased to announce a ground-breaking agreement with Canada’s Apollo Green. This agreement
marks a significant milestone in Rua Bioscience's strategy for growth by introducing its unique East
Coast Tairawhiti cannabis strains to the Canadian market ultimately creating another pathway for
revenue.

Apollo Green, a world leader in cannabis genetics, will now include Rua Bioscience's distinctive
strains in its genetic library, that includes over 1000 unique cultivars. This collaboration is a testament
to the global demand for diverse and high-quality cannabis genetics.

A wholly owned subsidiary of Biortica Agrimed, Apollo Green, has existing sales channels into
Europe, North America and Australasia. It is a market leader in genetic distribution and licensing.
Apollo Green provides access to breeder’s right protection through DNA fingerprinting of all genetics,
access to cultivation capabilities world-wide and licensing opportunities delivering increased revenue
opportunities to Rua Bioscience.

Biortica Agrimed is a leader in B2B medicinal cannabis cultivation and is one of Australia’s largest and
fastest growing producer of medicinal cannabis.

“We welcome Rua to the Apollo Green and the Biortica Agrimed family” said Tom Varga, CEO of
Biortica Agrimed.

The collaboration with Apollo Green enables the cultivation of Rua Bioscience's East Coast Tairawhiti
strains in Canada, broadening the horizons for both companies in the global cannabis market.

“This agreement not only highlights Rua Bioscience's commitment to innovation and quality but also
underscores the potential of New Zealand’s cannabis industry on the world stage.”

"We are excited about this partnership with Apollo Green and Biortica Agrimed, as it aligns perfectly
with our vision to take our unique strains to the world," said Paul Naske, CEO of Rua Bioscience.
"This is more than just an agreement; it's a bridge connecting New Zealand's exceptional cannabis
genetics to the world."


ENDS

The person who authorised this announcement:
Paul Naske,
Chief Executive Officer

For shareholder enquiries please visit www.ruabio.com or contact:
info@ruabio.com
0800 RUABIO



ANNOUNCEMENT

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
ABOUT RUA BIOSCIENCE
As one of few Māori-born biotech businesses in Aotearoa, Rua Bioscience is the only New Zealand-
based medicinal cannabis company with an explicit focus on delivering social impact. Licensed to
cultivate since 2016, Rua, was the first company founded by a Māori community to list on the New
Zealand stock exchange. Launching its first prescription medicine in April 2022. It’s strong social
conscience is evidenced by its introduction of one of New Zealand’s first Compassionate Access
schemes for medicinal cannabis.
www.ruabio.com
CONTACT: Paul Naske CEO, Rua Bioscience
paul.naske@ruabio.com
+64 21 445 154


ABOUT APOLLO GREEN

Licensed since July 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s
mission is to provide an ever-growing bank of seeds and clones to medical patients. Apollo Green
provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture
technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo
Green is passionate about cannabis genetics.

www.apollogreen.com


ABOUT BIORTICA

Biortica Agrimed Ltd is Australia’s largest fully vertically integrated commercial grower of medicinal
plants. Our B2B operations are seamlessly integrated from plant genetics through to supply of
medicinal plants in commercial quantities. We employ glasshouse-based horticulture, to both, protect
our valuable medicinal crops, and equally to minimise our environmental impact, thereby protecting
the planet. Our goal is to significantly improve human health outcomes by supplying high quality
agricultural medicinal plants, at scale, to uniform high quality standards year-round, year-on-year.

www.biortica.com

CONTACT: Tom Varga, CEO, Biortica Agrimed
e Tom Varga
tom.varga@biortica.com
m +61 499 991 745